| Execution period | 3 months |
|---|
BSE filing, NSE: ENGINERSIN. Summary written from the filing by ALFA Finder's alert engine.
Engineers India Ltd: key numbers
- Share price
- ₹256.35
- Market cap
- ₹14,408 Cr
- Revenue (annual)
- ₹3,928 Cr
- Net profit (annual)
- ₹691.6 Cr
- P/E (TTM)
- 18.4×Sector 43.1×
- Promoter holding
- 51.32%+0.00% QoQ
- FII holding
- 8.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Engineers India Ltd
All →Engineers India Legal & Regulatory
Engineers India's Board noted NSE and BSE fines totalling Rs.10,73,800 for Regulation 17(1) non-compliance. Waiver is sought; the government must appoint the missing independent directors.
- Value
- ₹0.11 Cr
Engineers India Legal & Regulatory
Engineers India Limited has commented on exchange fines of Rs.5,36,900 each from NSE and BSE for Regulation 17(1) non-compliance on board independent directors for the quarter ended June 30, 2026. The company has sought waiver, noting the shortfall is beyond its control.
- Value
- ₹1.07 Cr
Engineers India Board Meeting Date
Engineers India Limited has scheduled a board meeting for October 30, 2026. The board will consider and approve unaudited financial results for the quarter ended September 30, 2026.
Engineers India Other Announcement
Engineers India Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Engineers India Legal & Regulatory
Engineers India Limited reported board comments regarding fines of Rs.10.62 Lakh levied by NSE and BSE for non-compliance with SEBI LODR Regulation 17(1) independent director requirements.
- Value
- ₹0.11 Cr
Engineers India Bags ₹4,275 Cr Order from Dangote Group
EIL signed a ₹4,275 Crore PMC/EPCM contract with Dangote for Kenya's 700,000 BPD greenfield refinery. This strengthens East Africa's regional energy security.
- Value
- ₹4,275 Cr
- From
- Dangote Group
- refinery capacity
- 700000 BPD
Other regulatory approval announcements
All →Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.
Elantas Beck India Regulatory Approval
Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.
Kalyani Cast-Tech Regulatory Approval
Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.
Mukka Proteins Regulatory Approval
Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.
- Execution
- October 1, 2026 to December 31, 2027
Canara Bank Regulatory Approval
Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.
- Value
- ₹1,500 Cr
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.